2.34% -0.04

Inhibikase Therapeutics Inc (IKT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Inhibikase Therapeutics Inc-Aktie (IKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Selling, General, and Administrative	12.77% 5.9197	5.2493	5.7351	1.6376	1.9747
Costs And Expenses	25.80% 10.83	14.60	12.93	5.8275	5.0505
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	25.80% -10.83	-14.60	-12.93	-5.8275	-5.0505
Net Interest Income/Expense	0.27% 0.9168	0.9193	0.7961	0.0494	0.0909
Interest Income/Expense After Provision For Losses	0.27% 0.9168	0.9193	0.7961	0.0494	0.0909
Income/Loss From Continuing Operations Before Tax	20.81% -10.83	-13.68	-12.93	-5.8275	-4.9596
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	27.51% -9.9155	-13.68	-12.13	-5.7781	-4.9596
Net Income/Loss	27.51% -9.9155	-13.68	-12.13	-5.7781	-4.9596
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.53% 90.01	89.54	16.12	8.8826	7.5357
Diluted Average Shares	0.53% 90.01	89.54	16.12	8.8826	7.5357
Basic Earnings Per Share	26.67% -0.11	-0.15	0.87	-0.65	-0.66
Diluted Earnings Per Share	26.67% -0.11	-0.15	0.87	-0.65	-0.66
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%